- ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study with an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients with Acute Hepatic Porphyrias
- Code EudraCT: 2017-002432-17
- Protocol number: ALN-AS1-003
- Promoter: Alnylam Pharmaceuticals, INC
- Molecule/Drug: Givosiran
- LINK TO CLINICAL TRIALS
tal vezLE INTERESE
The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.
The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.
Learn why we are different from other healthcare centers. Quality, speed, comfort and results.